Browsing by Author Sala, A
Showing results 13 to 29 of 29
< previous
Issue Date | Title | Author(s) |
---|---|---|
2017 | Generation of a novel Antibody-Drug Conjugate targeting endosialin: potent and durable antitumor response in sarcoma | Sala, A |
2015 | Identification and pharmacological inactivation of the MYCN gene network as a therapeutic strategy for neuroblastic tumor cells | Chayka, O; D'Acunto, CW; Middleton, O; Arab, M; Sala, A |
30-Jun-2021 | Integrin-Targeted, Short Interfering RNA Nanocomplexes for Neuroblastoma Tumor-Specific Delivery Achieve MYCN Silencing with Improved Survival | Tagalakis, AD; Jayarajan, V; Maeshima, R; Ho, KH; Syed, F; Wu, L-P; Aldossary, AM; Munye, MM; Mistry, T; Ogunbiyi, OK; Sala, A; Standing, JF; Moghimi, SM; Stoker, AW; Hart, SL |
2020 | Investigating the role of exosomes in MYCN tumourigenesis and neuroblastoma | - |
2023 | Investigating the role of the MYB-BUB1 axis in adenoid cystic carcinoma | Cicirò, Ylenia |
19-Dec-2023 | The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma | Cicirò, Y; Ragusa, D; Nevado, PT; Lattanzio, R; Sala, G; Des Rochers, T; Millard, M; Andersson, M; Stenman, G; Sala, A |
2021 | Modelling the t(7;12) leukaemia using gene editing technology | Ragusa, Denise |
26-Feb-2021 | MYB oncoproteins: emerging players and potential therapeutic targets in human cancer | Cicirò, Y; Sala, A |
1-Dec-2021 | MYC regulates metabolism through vesicular transfer of glycolytic kinases | Tsakaneli, A; Carregari, VC; Morini, M; Eva, A; Cangemi, G; Chayka, O; Makarov, E; Bibbò, S; Capone, E; Sala, G; De Laurenzi, V; Poon, E; Chesler, L; Pieroni, L; Larsen, MR; Palmisano, G; Sala, A |
2020 | A novel cell and gene therapy approach for Friedreich's ataxia | Shaban, Enas |
2013 | Physical interaction between MYCN oncogene and polycomb repressive complex 2 (PRC2) in neuroblastoma: Functional and therapeutic implications | Corvetta, D; Chayka, O; Gherardi, S; D'Acunto, CW; Cantilena, S; Valli, E; Piotrowska, I; Perini, G; Sala, A |
2013 | Polyphenon E enhances the antitumor immune response in neuroblastoma by inactivating myeloid suppressor cells | Santilli, G; Piotrowska, I; Cantilena, S; Chayka, O; D'Alicarnasso, M; Morgenstern, DA; Himoudi, N; Pearson, K; Anderson, J; Thrasher, AJ; Sala, A |
2016 | A promyelocytic leukemia protein-thrombospondin 2 axis and the risk of relapse in neuroblastoma | Dvorkina, M; Nieddu, V; Chakelam, S; Pezzolo, A; Cantilena, S; Leite, AP; Chayka, O; Regad, T; Pistorio, A; Sementa, AR; Virasami, A; Barton, J; Montano, X; Lechertier, T; Brindle, N; Morgenstern, D; LE Bras, M; Burns, A; Saunders, N; Hodivala-Dilke, K; Bagella, L; de The, H; Anderson, J; Sebire, N; Pistoia, V; Sala, A; Salomoni, P |
2020 | Repurposing a psychoactive drug for children with cancer: p27Kip1-dependent inhibition of metastatic neuroblastomas by Prozac. | Sala, A |
9-Jul-2023 | RNAseq Analysis of Novel 1,3,4-Oxadiazole Chalcogen Analogues Reveals Anti-Tubulin Properties on Cancer Cell Lines | Zoroddu, S; Sanna, L; Bordoni, V; Lyu, W; Murineddu, G; Pinna, GA; Forcales, SV; Sala, A; Kelvin, DJ; Bagella, L |
15-Oct-2020 | Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma | Capone, E; Lamolinara, A; Pastorino, F; Gentile, R; Ponziani, S; Di Vittorio, G; D’Agostino, D; Bibbò, S; Rossi, C; Piccolo, E; Iacobelli, V; Lattanzio, R; Panella, V; Sallese, M; De Laurenzi, V; Giansanti, F; Sala, A; Iezzi, M; Ponzoni, M; Ippoliti, R; Iacobelli, S; Sala, G |
2011 | The tumour-suppressive function of CLU is explained by its localisation and interaction with HSP60 | Chaiwatanasirikul, KA; Sala, A |